Nuoncology Labs Inc
OTC:NLAB
Nuoncology Labs Inc
Operating Income
Nuoncology Labs Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
N
|
Nuoncology Labs Inc
OTC:NLAB
|
Operating Income
-$29.2k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Montrose Environmental Group Inc
NYSE:MEG
|
Operating Income
-$22.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
DermTech Inc
NASDAQ:DMTK
|
Operating Income
-$103.7m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-142%
|
CAGR 10-Years
N/A
|
|
Sotera Health Co
NASDAQ:SHC
|
Operating Income
$276.7m
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Sera Prognostics Inc
NASDAQ:SERA
|
Operating Income
-$39.8m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Spectaire Holdings Inc
NASDAQ:SPEC
|
Operating Income
-$7.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Nuoncology Labs Inc's Operating Income?
Operating Income
-29.2k
USD
Based on the financial report for Dec 31, 2021, Nuoncology Labs Inc's Operating Income amounts to -29.2k USD.